Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial | Zendy

JaeHong Kim | Zendy; Michael Cho | Zendy; Jaehee Yoo | Zendy; Gwang-Cheon Park | Zendy; Jeong-Soon Lee | Zendy

Open Access

Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial

Author(s) -

JaeHong Kim,

Michael Cho,

Jaehee Yoo,

Gwang-Cheon Park,

Jeong-Soon Lee

Publication year - 2022

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-22-701

Subject(s) - medicine , cognitive impairment , cognition , placebo , randomized controlled trial , clinical trial , anxiety , disease , physical therapy , psychiatry , alternative medicine , pathology

It is important to develop effective treatments to prevent the progress of mild cognitive impairment to Alzheimer's disease. Cheonwangbosimdan has been widely prescribed for palpitation, anxiety, insomnia, and memory decline. We aimed to obtain clinical trial data concerning the safety and efficacy of Cheonwangbosimdan for mild cognitive impairment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research